Masimo (Nasdaq: MASI), the inventor of Pulse CO-Oximetry(TM) and Measure-Through Motion and Low-Perfusion pulse oximetry, announced today that Children's Hospital & Research Center Oakland has completed its system-wide conversions to Masimo Rainbow SET Pulse CO-Oximetry technology. Standardizing to Masimo Rainbow SET makes Children's Hospital Oakland the first children's hospital to pioneer new continuous noninvasive blood monitoring capabilities hospital-wide--allowing earlier and better clinical decisions without the intermittent pain and wait associated with drawing blood.
By converting to Masimo Rainbow SET, Children's Hospital Oakland clinicians will gain all the benefits and Measure-Through Motion capabilities of Masimo SET pulse oximetry, along with the breakthrough innovation of the first-ever continuous and noninvasive hemoglobin monitoring (SpHb(TM)) technology. Noninvasive hemoglobin will allow clinicians at Children's to detect and treat chronic or acute anemia earlier, identify internal bleeding sooner, and more effectively manage blood transfusions for their patients. The ability to immediately detect and treat potentially life-threatening conditions earlier may help save lives and improve patient outcomes.
Katie Sabato, MS, RRT, director of Respiratory Care, Pulmonary Function & Sleep Labs at Children's Hospital Oakland, stated, "All of our efforts are focused on helping kids get better, which requires a very special level of care and some of the world's most sophisticated technology. Masimo Rainbow SET will allow us to measure critical components of a child's blood quickly and easily, without the pain of a needle stick and the discomfort of having blood drawn. It's also a great example of how we leverage advanced technology and innovative care solutions to improve comfort and care and speed-up a child's recovery."